Hobart Private Capital’s GSK GSK Stock Holding History

Hobart Private Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-7,787	Closed	-$366K	–	152
2020 Q3	$366K	Sell	7,787 -9,437	-55%	-$473K	0.19%	109
2020 Q2	$878K	Sell	17,224 -8,619	-33%	-$442K	0.49%	47
2020 Q1	$1.22M	Sell	25,843 -3,764	-13%	-$201K	0.84%	31
2019 Q4	$1.74M	Buy	29,607 +1,585	+6%	+$88.2K	1.06%	27
2019 Q3	$1.49M	Buy	28,022 +125	+0.4%	+$6.43K	1.02%	26
2019 Q2	$1.4M	Sell	27,897 -1,533	-5%	-$76.9K	0.97%	27
2019 Q1	$1.54M	Sell	29,430 -3,688	-11%	-$184K	1.17%	23
2018 Q4	$1.58M	Buy	33,118 +3,796	+13%	+$187K	1.36%	21
2018 Q3	$1.47M	Buy	29,322 +3,646	+14%	+$185K	1.13%	27
2018 Q2	$1.29M	Sell	25,676 -1,795	-7%	-$90.4K	1.05%	31
2018 Q1	$1.34M	Buy	27,471 +915	+3%	+$42.6K	1.18%	25
2017 Q4	$1.18M	Buy	+26,556	New	+$1.23M	1.05%	31

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada

Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return